Compound ID | 1226
Class: Quinolone
| Spectrum of activity: | Gram-positive |
| Details of activity: | C. difficile infection |
| Institute where first reported: | Otsuka Pharmaceutical Co. Ltd. |
| Highest development stage: | Phase 2 |
| Development status: | Active |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/71289877 |
| Guide to Pharmacology: | OPS-2071 |
| Citation: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336415/ |